Category: Variants
London School of Hygiene & Tropical Medicine study: “we estimate a 71% higher hazard of death associated with VOC 202012/01” [B.1.1.7]
“Correcting for misclassification of SGTF and missingness in SGTF status, we estimate a 71% (48–97%) higher hazard of death associated with VOC 202012/01. More...
New coronavirus variant B.1.525 with E484K, Q677H, F888L and a similar deletions to B117
International lineage with variants of biological significance E484K, Q677H, F888L and a similar suite of deletions to B.1.1.7. More...
NERVTAG: increased disease severity in people infected with coronavirus variant B.1.1.7
NERVTAG: “Here we report updated and additional analyses, which together strengthen the earlier finding of increased disease severity in people infected with VOC B.1.1.7 compared to other virus variants.” More...
California coronavirus variant CAL.20C accounts for nearly half of COVID-19 cases in Southern California and about a 1/3 of cases in the state
The CAL.20C variant accounts for nearly half of COVID-19 cases in Southern California and about a third of cases in the state based on an analysis of viral genomes posted to a global database called GISAID. More...
B.1.1.7 Kent coronavirus variant now at 28% in Denmark
The UK B.1.1.7 variant was detected in 28.5 percent of the samples in Denmark sequenced up to Friday 12th February 2021 from the first week of February 2021. More...
Scientist warns of 3rd wave of Coronavirus in Manaus, Brazil
In August 2020, Brazilian researcher Lucas Ferrante warned authorities of a 2nd wave of coronavirus in Manaus, Brazil in this article – an event which subsequently occurred and has been widely reported. More...
14 people test positive for B.1.1.7 coronavirus in Osnabrück despite having 2nd vaccine jab
14 vaccinated retirement home residents tested positive for B.1.1.7 UK coronavirus variant
There has been an outbreak of the British variant of coronavirus in a retirement and nursing home in the Belm district of Osnabrück in Germany. More...
Oxford University: “vaccine effective against major B.1.1.7 ‘Kent’ coronavirus strain circulating in the UK”
“Data from our trials of the ChAdOx1 vaccine in the United Kingdom indicate that the vaccine not only protects against the original pandemic virus, but also protects against the novel variant, B.1.1.7”
The Oxford University researchers who developed the ChAdOx1-nCoV 19 vaccine have found that it remains effective against one of the new variants of the disease. More...
Circulating SARS-CoV-2 variants B.1.1.7, 501Y.V2, and P.1 have gained ability to utilize rat and mouse Ace2 and altered in vitro sensitivity to neutralizing antibodies and ACE2-Ig
Here, we first investigated cross-species receptor usage of multiple SARS-CoV-2 variants that emerged during the pandemic. More...
Reinfection from SARS-CoV-2 lineage P.2 with the E484K spike mutation in Brazil
We report the first case of reinfection from genetically distinct SARS-CoV-2 lineage [P.2] presenting the E484K spike mutation in Brazil, a variant associated with escape from neutralizing antibodies. More...